Innate Pharma
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-06-30 |
|---|---|---|---|
Revenue | $4,860 | $276 | $12,345 |
Gross Profit | -15,660 | 29,352 | -16,731 |
EBITDA | -25,061 | -21,348 | -25,563 |
EBIT | -25,427 | -22,592 | -26,313 |
Net Income | -21,344 | -24,707 | -24,764 |
Net Change In Cash | 4,860 | 276 | 12,345 |
Free Cash Flow | -31,222 | -10,040 | 2,753 |
Cash | 53,704 | 66,396 | 69,990 |
Basic Shares | 86,936 | 81,052 | 80,872 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $12,621 | $51,901 | $57,674 | $12,112 |
Gross Profit | 12,621 | 5,619 | 6,011 | -22,301 |
EBITDA | -46,911 | -1,839 | -12,279 | -43,229 |
EBIT | -48,905 | -6,930 | -57,684 | -47,825 |
Net Income | -49,471 | -7,570 | -58,103 | -52,809 |
Net Change In Cash | 12,621 | 51,901 | 57,674 | 12,112 |
Free Cash Flow | -7,287 | -34,909 | -20,276 | -59,787 |
Cash | 66,396 | 70,605 | 84,225 | 103,756 |
Basic Shares | 81,052 | 84,111 | 79,639 | 79,542 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.29 |
2025-03-31 | -$0.30 |
2024-12-31 | -$0.30 |
